Although the precise mechanism of LRIG1 downregulation in cancer cells remains unclear, the findings of a recent study demonstrated that LRIG1 forms a ternary complex between LRIG1, E-cadherin, and EGFR, which upon cell-to-cell contact negatively regulates EGFR signaling [30]. The gene discussed is LRIG1; the disease is cancer.